AHRQ

Dear Research Advocate, I was honored to speak yesterday to a group of early-career global health researchers, plus alums and mentors, gathered for orientation and training under the auspices of NIH’s Fogarty International Center. Following my prepared remarks we had a terrific informal discussion. A question from a researcher who had grown up in Kentucky triggered a thoughtful exchange: “how do I explain the value of my work to a resident of rural Kentucky, including why her taxes should pay for it?” These two linked but separate questions can seem quite daunting if, like most researchers, you have never been oriented, much less trained, to consider the public context of research. We’re...
Dear Research Advocate, Former Congressman John Porter, Research!America’s esteemed Chair Emeritus, does not mince words in his Washington Post LTE today, cautioning against state-level education policies that could be misused to subvert science education. Treating knowledge that has been affirmed by years of scientific exploration as negotiable jeopardizes our nation’s ability to meet the challenges and seize the opportunities before us. It is a path to decline rather than progress. We cannot afford to shy away from straight talk about misguided policies. Fortunately for our nation, John never does. This afternoon, the House Labor-H Subcommittee, formerly chaired by Mr. Porter, “marked up...
Dear Research Advocate, I hope you had an opportunity to read America’s ‘Miracle Machine’ is in desperate need of, well, a miracle in last Friday’s Washington Post. The authors, Eric S. Lander and Eric E. Schmidt, build a case for “investing in curiosity about the natural world” that exemplifies advocacy at its most compelling. The term “aha moment” may be overused, but it applies to this commentary as surely as it does to President Franklin Roosevelt’s remarks on the dedication of the NIH’s then-new campus in 1940, when he proclaimed: “We cannot be a strong nation unless we are a healthy nation. And so we must recruit not only men and materials, but also knowledge and science in the...
Dear Research Advocate, Last weekend’s March for Science truly was a celebration and a success. That so many passionate advocates participated -- hundreds of thousands in cities across the globe (some in the pouring rain) -- was awe-inspiring. Following the March, Research!America signed onto a community statement that gives voice to the importance of continued civic engagement by scientists and our commitment to fostering that engagement. At the D.C. March, we were thrilled to see two Research!America board members, APHA executive director, Dr. Georges Benjamin, and AAAS CEO and former Congressman, Dr. Rush Holt, among the speakers, and our video up on the jumbotrons. Some Research!America...
Dear Research Advocate, House Republican Leadership released an ACA replacement bill this week (section summaries available from the Energy & Commerce and Ways & Means committees). The bill has been creating waves, concerning many in the public health and health care fields. The cost and coverage impact have yet to be estimated, but we do know that the bill repeals the Prevention and Public Health Fund (PPHF), which accounts for approximately 12% of CDC’s budget. House Labor-H Chairman Cole (R-OK) discussed CDC’s crucial role in a recent STAT article. Use this editable message to make the case for CDC and PPHF. Trust for America’s Health is a terrific resource for more background...
Dear Research Advocate, I have exciting news! Joe Biden, the 47th Vice President of the United States, will join us at our 21st Annual Advocacy Awards Dinner on March 15 to receive the Gordon and Llura Gund Leadership Award . As he has demonstrated through his leadership of the Cancer Moonshot Initiative, his work in Congress, and in so many other ways, the former Vice President is a true advocate for research. Join us for a remarkable evening. A foundational goal for this annual event is to spotlight advocates for science -- often those who both practice and champion it -- as embodying the “secret sauce” that empowers science by driving public and policymaker support. More scientists are...
Dear Research Advocate, As I reflect on the accomplishments of the year for advocacy for research and innovation, the passage of the 21st Century Cures Act is foremost in my mind, but more work lies ahead as it is executed and more work broadly speaking, to ensure that research for health -- and science and innovation overall -- is treated as a top national priority for the incoming Administration and Congress. I discussed this at UConn’s Connecticut Institute for Clinical and Translational Science (CICATS) Kavli Seminar last week, emphasizing that all of us who care about our scientific enterprise must step up our engagement with decision-makers. I invite you to view the presentation or...
The recent presidential town hall debate didn’t even touch on the critical role science and research play in our nation’s health, security and prosperity. There is one more debate, October 19th, and with the topics already announced , now is the time to suggest questions to moderator Chris Wallace and his Fox producers by tweeting to @FoxNews and @FoxNewsSunday. The list of topics for the debate doesn’t include science in a direct way; however, the economy is on the list, presenting a clear opportunity to ask what each candidate would do to fuel research and innovation in the interest of creating good jobs and driving the economy. In a recent opinion piece , Bill Gates lays out how...
Dear Research Advocate: Today, the House Labor-HHS appropriations subcommittee marked up its FY17 funding bill, which includes funding for NIH, CDC and AHRQ. NIH received a $1.25 billion increase, $750 million less than the Senate increase. Given the subcommittee’s overall budget allocation ($569 million below fiscal year 2016) and the more conservative funding climate in the House, this is still an extraordinarily positive outcome. At the markup, Chairman Tom Cole (R-OK-04) noted that the $1.25 billion increase set a floor - rather than a ceiling - for NIH funding in FY17, a positive sign for potential negotiations with the Senate later in the process. The House Labor-HHS bill proposes a...
Dear Research Advocate: If you’ve read Ron Chernow’s “Hamilton,” you know that the partisan stand-off we are witnessing in the House, and more broadly across the nation, is not new. Chernow reminds us that political parties -- not originally foreseen by the Founding Fathers -- grew out of intense and often ugly disagreements between Alexander Hamilton and Thomas Jefferson during the second administration of George Washington. That insight doesn’t make this week’s turn of events less dramatic, but it does offer perspective. In the midst of the Democratic sit-in on preventing gun violence, the House adjourned earlier than expected and won’t resume business until July 5. Just before adjourning...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient